AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Utilizing Whole Body Imaging and Mass Spectrometry for Early Screening of Amyloidosis
This chapter explores the potential of using whole body imaging and mass spectrometry for early screening of amyloidosis, focusing on studying light chain glycosylation and other post-translational modifications. The speakers discuss the impact of lowering light chains and the importance of comprehensive risk stratification systems that consider patient characteristics and bone marrow genetics.